Showing results (2521-2530 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|May 10, 2020
Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.SAshley A Leech, Peter J Neumann, Joshua T Cohen, et al.
The Oncologist|April 25, 2020
The Relationship Between Imaging and Thyroid Cancer Diagnosis and SurvivalMegan R Haymart, David Reyes-Gastelum, Elaine Caoili, et al.
The Oncologist|April 23, 2020
Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular LymphomaFrédérique St-Pierre, Stephen M Broski, Betsy R LaPlant, et al.
The Oncologist|April 21, 2020
The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland CancersGlenn J Hanna, Ji Eun Bae, Jochen H Lorch, et al.
The Oncologist|September 2, 2021
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast CancerRomualdo Barroso-Sousa, Ines Vaz-Luis, Antonio Di Meglio, et al.
The Oncologist|September 19, 2025
Toxicity-benefit analysis of advanced prostate cancer trials using weighted toxicity scoringJaspreet K Gill, Rubens C Sperandio, Tuan Hoang, et al.
The Oncologist|September 19, 2025
Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancerOlatunji B Alese, Robert Donald Harvey, Christina Wu, et al.
The Oncologist|September 20, 2025
Management of acral melanoma with lymph node macrometastasis in the post-MSLT-II era: focus on the effect and timing of lymph node dissectionChengcai Liang, Huajie Guan, Xunyi Long, et al.
The Oncologist|September 20, 2025
Survival analysis of pyrotinib in HER2-positive metastatic breast cancer: a multicenter real-world studyShiyi Li, Ting Xu, Chengjun Zhu, et al.
The Oncologist|September 20, 2025
The past, present, and future of myeloma staging and risk prognosticationMehmet Baysal, Kelley Julian, Douglas Sborov, et al.
Pageof 571